Hence, pharmacological inhibition of MAGL was able to reduce tumor volume, which was further associated with downregulation of fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) [15]. The gene discussed is FGF2; the disease is neoplasm.